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Abstract: Combined intakes of specific dietary fiber and fat subtypes protect against colon cancer in
animal models. We evaluated associations between self-reported individual and combinations of
fiber (insoluble, soluble, and pectins, specifically) and fat (omega-6, omega-3, and docosahexaenoic
acid (DHA) and eicosapentaenoic acid (EPA), specifically) and colorectal cancer (CRC) risk in the
Women’s Health Initiative prospective cohort (n = 134,017). During a mean 11.7 years (1993–2010),
1952 incident CRC cases were identified. Cox regression models computed multivariate adjusted
hazard ratios to estimate the association between dietary factors and CRC risk. Assessing fiber and
fat individually, there was a modest trend for lower CRC risk with increasing intakes of total and
insoluble fiber (p-trend 0.09 and 0.08). An interaction (p = 0.01) was observed between soluble fiber
and DHA + EPA, with protective effects of DHA + EPA with lower intakes of soluble fiber and an
attenuation at higher intakes, however this association was no longer significant after correction for
multiple testing. These results suggest a modest protective effect of higher fiber intake on CRC risk,
but not in combination with dietary fat subtypes. Given the robust results in preclinical models and
mixed results in observational studies, controlled dietary interventions with standardized intakes are
needed to better understand the interaction of specific fat and fiber subtypes on colon biology and
ultimately CRC susceptibility in humans.
Keywords: butyrate; colorectal cancer; DHA; EPA; fat; fiber; omega-3; pectin
1. Introduction
Colorectal cancer (CRC) is the third most common type of cancer in the U.S., accounting for
roughly 8% of new cancer cases and 8% of all cancer deaths in 2015 [1]. Lifestyle factors such as
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diet, physical activity, and body weight contribute substantially to CRC, and it is generally held
that risk could be greatly reduced through dietary modification [2]. Dietary fiber and fat are two of
the most well-studied dietary components in this regard [3]. Although many case-control studies
have found inverse associations between fiber and fat intakes and CRC [4], data from epidemiologic
studies are mixed [4–25], possibly due to differences in intake assessment, the type of fiber or fat
analyzed, and residual confounding by other lifestyle and dietary factors. More recent studies have
attempted to control for dietary confounders such as folate, alcohol, and red meat consumption, yet
the contradictions in outcomes persist [7,15,26,27]. Finally, within the Women’s Health Initiative (WHI)
Dietary Modification Trial, a low fat dietary pattern intervention which included a focus on increasing
servings of whole grains, vegetables, and fruits, was found to have no significant benefit on CRC
incidence over an average of 8.1 years [28].
There is a growing recognition that dietary exposures are complex with synergistic and
antagonistic effects between different dietary components contributing to chronic disease risk.
Interactions between dietary constituents and microbial metabolites may also partially explain
differences in population-level study outcomes [29,30]. In contrast to the equivocal data from
observational studies in humans—in which each dietary component is evaluated separately—strong
evidence for a combined effect of the subtypes of fat and fiber in relation to reduced colon tumorigenesis
has been demonstrated in preclinical animal models [31–35]. Gut bacteria ferment dietary fiber
(e.g., pectins, a type of fermentable soluble fiber) to butyrate [36–49], a potent histone deacetylase
(HDAC) inhibitor [29,30] associated with reduced CRC risk [50–52]. Omega 6 (n-6) polyunsaturated
fatty acids (PUFA), commonly found in refined vegetables oils, processed and fast foods, and red
meat, typical in Western diets [53], and omega 3 (n-3) PUFA in fish oils [54] are structural precursors of
eicosanoids; those derived from n-6 are mainly pro-inflammatory, whereas those produced from n-3
tend to have opposing effects [55,56]. Given the strong correlation between inflammation and CRC [56],
higher intakes of long-chain n-3 PUFA provide biologic validity for a chemoprotective effect [57].
Preclinical research suggests that the combined effects of n-3 PUFA in fish oils
(e.g., docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA)) and butyrate from fermentable
fiber (e.g., pectin) may work in concert to enhance the chemopreventive potential of either dietary
component alone, primarily by increasing apoptosis [31,33,34,58–62]. While other factors, such as low
dietary intakes of fiber and certain fatty acid subtypes, may contribute to the mixed results in humans,
the lack of evaluation of the interaction between subtypes of dietary fat and fiber, i.e., pectins in soluble
fiber and marine-derived n-3 PUFA, may also explain why the chemoprotective effects of fiber and fat
have not been consistently detected in prospective cohort studies. Therefore, our objectives for this
study were to determine the associations between the individual and combinations of subtypes of
fiber (soluble, and pectins specifically, which leads to the production of butyrate, vs. insoluble) and fat
(n-3, and DHA + EPA, specifically, vs. n-6), and risk of CRC in the WHI.
2. Materials and Methods
2.1. Study Population
The WHI is a large prospective study focused on understanding preventive strategies for major
chronic diseases in postmenopausal women [63]. WHI includes both a multi-component randomized
Clinical Trial (CT) and an Observational Study (OS). The CT (n = 68,132) was actually three overlapping
randomized controlled trials evaluating combined hormone therapy or estrogen alone versus placebo
(HRT), a low-fat dietary pattern versus comparison (Dietary Modification), and calcium and vitamin D
supplementation versus placebo (CaD), on the risk of breast and colorectal cancers, coronary heart
disease, and osteoporotic fractures. The OS (n = 93,676) examines a broader range of lifestyle, health,
and risk factors and risk of common chronic diseases in postmenopausal women initially interested
in but ineligible for one or more of the clinical trials. Postmenopausal women aged 50–79 years
were recruited from the general population at 40 different Clinical Centers between 1993 and 1998,
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with trial follow-up information and outcome data available through 2005, and post-trial follow-up
information and outcome data for these analyses available through September, 2010, the end of
the first WHI Extension Study. All participants in the CT and OS were included in the present
analysis except women who were randomized to the intervention arm of the Dietary Modification trial
(n = 19,541). Further details on recruitment, study design, and baseline measures have been published
elsewhere [63–66]. Institutional review board approval was obtained from all clinical sites, and women
provided written informed consent prior to participation and for follow-up in the Extension period.
The WHI ClinicalTrials.gov identifier is NCT00000611.
2.2. Data Collection and Dietary Assessment
Detailed information on demographic characteristics, medical, reproductive and familial CRC
history, and lifestyle factors were collected at baseline. Weight and height were assessed with a
standardized protocol using a calibrated balance beam scale and stadiometer, respectively, and
body mass index (BMI) was computed as weight in kg/height in m2. Physical activity was
assessed by computing average weekly metabolic equivalents of moderate and vigorous leisure-time
physical activity.
Dietary intake over the past three months was measured from the WHI food frequency
questionnaire (FFQ) [67] using a standardized protocol at baseline for all women, and at year one for
Dietary Modification CT participants. Follow-up FFQs were completed in years two through nine
for a rotating proportion (33%) of Dietary Modification CT participants. The baseline FFQ data were
used for the current study. The FFQs contained 122 food and food group items, and 19 adjustment
questions, the majority of which ask about food practices pertaining to types and amounts of added
fats (e.g., fat added at the table and in cooking), and three summary questions on food purchasing and
preparation methods [67]. The WHI nutrient database was derived from Nutrition Data Systems for
Research (NDS-R, version 2005, Nutrition Coordinating Center, University of Minnesota, Minneapolis,
MN, USA). The database has over 140 nutrient values including total fat, total PUFA, n-6 and n-3
PUFA, total DHA and EPA from food sources; and total, insoluble and soluble fiber, and pectins.
2.3. Colorectal Cancer Case Ascertainment
Clinical outcomes, including cancer diagnoses, were updated annually in the OS and
semi-annually in the CT until 2005 when the outcomes were thereafter reported annually using mail or
telephone questionnaires. Self-reports of CRC were verified by trained physician adjudicators at the
Clinical Centers who reviewed medical records and pathology reports [68]. All CRC diagnoses were
then confirmed by blinded review at the WHI Clinical Coordinating Center at the Fred Hutchinson
Cancer Research Center.
2.4. Statistical Analysis
Exclusions were made for women who reported history of colon or rectal cancers prior to baseline
enrollment or who were missing these data (n = 946). Further exclusions were made for women with
FFQs containing incomplete information, or data that suggested biologically implausible daily energy
intakes of <2512 or >20,930 kJ (n = 4649), or extreme BMIs (<15 or >50 kg/m2; n = 2069). Finally,
women who were missing data for smoking, physical activity, and education variables combined
(n = 9), or were lost to follow up (n = 577), were excluded, leaving a sample of 134,017 for analysis.
Cox proportional hazards models were used to estimate hazard ratios (HR) and 95% confidence
intervals (95% CI) for the association of fiber (total, insoluble, soluble, and pectins) and fat (total, n-6,
n-3, and DHA + EPA) intakes and CRC risk. Dietary variables were evaluated as separate main effects,
as quintiles of intake, using the lowest quintile as the reference group. Quintile assignments of dietary
variables from the baseline FFQ were calculated based on the distribution in non-cases. Tests for
trend were performed in a separate Cox model treating quintiles 1–5 as linear. Fat variables were
analyzed both as g intake/day with energy adjusted in the models, and as % energy. As the results
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for both were similar (data not shown) we present only fat as g intake/day. Interactions (a total of
seven determined a priori: total fat × total fiber; insoluble fiber × n-6 PUFA; soluble fiber × n-3 PUFA;
insoluble fiber × n-3 PUFA; soluble fiber × DHA + EPA; pectins × n-3 PUFA; pectins × DHA + EPA)
were assessed by adding the multiplicative interaction term between linear quintiles of dietary fat
and fiber variables to the final multivariate model. For the significant interaction of soluble fiber and
DHA + EPA, post-hoc HRs and 95% CIs were computed for each quintile comparison for each of the
25 fat × fiber groups.
All models were adjusted for established or suggestive risk factors for CRC: (age (years,
continuous); family history of CRC (yes/no); red and processed meat consumption (g/day, continuous);
BMI (kg/m2, continuous); leisure physical activity (total metabolic equivalent-h/week, continuous);
smoking (current or past/never); alcohol use (g/day, continuous); current use of non-steroidal
anti-inflammatory drugs (NSAIDs; yes/no); folate (food plus supplements; µg dietary folate
equivalents/day, continuous); calcium (food plus supplements; mg/day; continuous)) [69,70], and
confounders that altered point estimates for dietary outcome measures by more than 10%: total energy
intake (kcal/day, continuous); history of screening colonoscopy (yes/no); education level (high school;
technical school or some college; college grad or post); ever use of menopausal hormones (yes/no);
and study component (OS, CT) and CT randomization assignment (HRT, Dietary Modification or
CaD). We created a “missing” category for covariates with data missing for <0.5% of the participant
population (NSAIDs, n = 91, smoking, n = 1737, education level, n = 1005, and colonoscopy screening,
n = 4736), and imputed the median values for physical activity (n = 5230) to reduce the number of
participants who would be dropped from the analysis. All tests for individual dietary factors were two
sided and statistical significance was set at p < 0.05. Tests for interaction were adjusted for multiple
testing using Bonferroni correction (0.05/7 tests conducted = p < 0.007). All analyses were conducted
using Stata (v14.1; StataCorp, College Station, TX, USA).
3. Results
The distribution of baseline participant characteristics and dietary intake for CRC cases and
non-cases are given in Table 1. During a mean follow up of 11.7 years (±3.5; range: 0.02–17.5 years),
a total of 1952 CRC cases were reported. Women with CRC appeared less likely to have ever used
hormone therapy and consumed less calcium. Intakes of all other dietary variables were very similar
in cases and non-cases.
Table 1. Baseline characteristics, colorectal cancer risk factors, and dietary constituents for participants
in the Women’s Health Initiative 1993–2010 1.
Characteristic Cases (n = 1952) Non-Cases (n = 132,065)
Age, (years) 66 (6.9) 63 (7.3)
Height (cm) 162 (6.3) 162 (6.4)
Body mass index (kg/m2) 28 (5.7) 28 (5.5)
Race (%)
White 85 84
Black 9 8
Other/Unknown 2 6 8
Education (% college graduate) 38 40
Screening colonoscopy (%) 49 51
Family history of CRC (%) 19 15
NSAID (% current use) 17 19
Alcohol use at baseline (g/day) 5 (11.3) 5 (10.8)
Never smokers (%) 49 50
Physical activity (MET-h/week) 3 12 (12.6) 13 (13.7)
Ever used post-menopausal Hormone therapy (%) 48 56
Dietary intake
Total energy (kJ/day) 6766 (2671) 6787 (2642)
Total fiber (g/day) 16 (6.9) 16 (6.9)
Soluble fiber (g/day) 4.3 (1.8) 4.3 (1.8)
Pectins (g/day) 2.5 (1.2) 2.5 ( 1.2)
Insoluble fiber (g/day) 11.5 (5.1) 11.8 (5.1)
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Table 1. Cont.
Characteristic Cases (n = 1952) Non-Cases (n = 132,065)
Total fat (g/day) 60 (32.7) 59 (32.0)
n-3 (g/day) 1.41 (0.8) 1.41 (0.8)
DHA + EPA (g/day) 0.12 (0.12) 0.13 (0.12)
n-6 (g/day) 10.8 (6.2) 10.7 (6.2)
Linoleic acid (g/day) 10.8 (6.2) 10.7 (6.1)
Linolenic acid (g/day) 1.3 (0.7) 1.3 (0.7)
Calcium (mg/day) 803 (439) 827 (453)
Folate (DFE, µg/day) 478 (206) 488 (207)
Red meat (g/day) 0.69 (0.57) 0.67 (0.55)
1 Means (Standard Deviation) unless otherwise specified; 2 Includes Hispanic, American Indian, Asian/Pacific
Islander, Mixed races, and Refused; 3 Total metabolic equivalent-hours/week. CRC, colorectal cancer; DFE,
dietary folate equivalents; DHA, docosahexaenoic acid; EPA, eicosapentaenoic acid; NSAIDs, non-steroidal
anti-inflammatory drugs.
Table 2 provides data on associations of total, insoluble, and soluble fiber, and pectins, with CRC
risk. When assessing fiber as a main effect, higher versus lower total soluble and insoluble fibers were
associated with modest, but non-significant lower risk of CRC. There was a suggestion of inverse linear
trends for total and insoluble fiber, (p-trend = 0.09 for total fiber; p-trend = 0.08 for insoluble fiber).
Table 2. Multivariate-adjusted hazard ratios and 95% CIs for the association of fiber with colorectal
cancer in the Women’s Health Initiative (n = 134,017) 1993–2010.
Quintiles of Dietary Intake No. Cases Person-Years Multivariate Adjusted HR (95% CI) 1
Total fiber (g/day)
<10.3 420 302,828 1.00 (Reference)
10.3–13.6 426 312,546 1.00 (0.87, 1.15)
13.6–17.0 354 316,244 0.83 (0.71, 0.97)
17.0–21.5 372 318,893 0.87 (0.74, 1.03)
>21.5 380 318,844 0.90 (0.73, 1.10)
p-trend 0.09
Soluble fiber (g/day)
<2.8 408 304,051 1.00 (Reference)
2.8–3.7 409 312,599 0.97 (0.84, 1.12)
3.7–4.6 361 316,928 0.85 (0.73, 1.00)
4.6–5.8 410 318,628 0.96 (0.81, 1.13)
>5.8 364 317,148 0.84 (0.69, 1.03)
p-trend 0.14
Insoluble fiber (g/day)
<7.4 433 302,242 1.00 (Reference)
7.4–9.8 413 312,804 0.93 (0.81, 1.07)
9.8–12.3 357 316,721 0.81 (0.69, 0.94)
12.3–15.7 370 318,704 0.84 (0.72, 1.00)
>15.7 379 318,884 0.87 (0.72, 1.06)
p-trend 0.08
Pectin (g/day)
<1.4 399 303,832 1.00 (Reference)
1.4–2.0 397 313,746 0.97 (0.84, 1.12)
2.0–2.6 379 316,302 0.92 (0.79, 1.06)
2.6–3.5 396 318,847 0.97 (0.83, 1.13)
>3.5 381 316,626 0.94 (0.80, 1.11)
p-trend 0.56
1 The following variables were included in both the multivariate and continuous models: total energy intake
(continuous), age (continuous), body mass index (continuous), education (high school, technical school or
some college, college graduate or post-graduate), family history of colorectal cancer (yes/no), history of
colonoscopy (yes/no), current NSAID use (yes/no), alcohol intake (continuous), smoking history (never,
former, current), physical activity (total metabolic equivalent-hours, continuous), ever use of hormone therapy
(never, current/former), folate (DFE; µg/day, continuous), calcium (mg/day, continuous), and red meat
intake (g/day, continuous), and study component (OS, CT) and CT randomization assignment and treatment
arm. OS, observational study; CT, clinical trial; DFE, dietary folate equivalents; NSAIDs, non-steroidal
anti-inflammatory drugs.
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The associations of total fat, n-6 PUFA, n-3 PUFA, and EPA + DHA with CRC risk were null with
most HRs near the null value of 1.0 (Table 3).
Table 3. Multivariate-adjusted hazard ratios and 95% CIs for the association of fat with colorectal
cancer in the Women’s Health Initiative (n = 134,017) 1993–2010.
Quintiles of Dietary Intake No. Cases Person-Years Multivariate Adjusted HR (95% CI) 1
Total fat (g/day)
<33.1 345 309,005 1.00 (Reference)
33.1–45.6 432 318,884 1.20 (1.04, 1.39)
45.6–59.7 394 316,808 1.05 (0.90, 1.24)
59.7–80.6 381 316,629 0.98 (0.82, 1.18)
>80.6 400 313,067 0.98 (0.76, 1.27)
p-trend 0.44
n-6 PUFA (g/day)
<5.9 375 309,046 1.00 (Reference)
5.9–8.1 405 314,292 1.02 (0.88, 1.18)
8.1–10.7 390 316,554 0.95 (0.81, 1.11)
10.7–14.6 394 317,021 0.92 (0.78, 1.09)
>14.6 388 312,441 0.84 (0.68, 1.05)
p-trend 0.10
n-3 PUFA (g/day)
<0.80 401 308,532 1.00 (Reference)
0.80–1.09 389 314,521 0.94 (0.82, 1.08)
1.09–1.41 383 316,931 0.90 (0.78, 1.05)
1.41–1.90 377 316,759 0.87 (0.75, 1.03)
>1.90 402 312,611 0.90 (0.74, 1.09)
p-trend 0.16
DHA + EPA (g/day)
<0.04 402 307,408 1.00 (Reference)
0.04–0.07 389 312,402 0.97 (0.84, 1.12)
0.07–0.11 393 315,998 0.98 (0.85, 1.13)
0.11–0.18 389 318,148 0.99 (0.85, 1.14)
>0.18 379 315,397 0.98 (0.84, 1.13)
p-trend 0.87
1 The following variables were included in both the multivariate and continuous models: total energy intake
(continuous), age (continuous), body mass index (continuous), education (high school, technical school or
some college, college graduate or post-graduate), family history of colorectal cancer (yes/no), history of
colonoscopy (yes/no), current NSAID use (yes/no), alcohol intake (continuous), smoking history (never,
former, current), physical activity (total metabolic equivalent-hours, continuous), ever use of hormone therapy
(never, current/former), folate (DFE µg/day, continuous), calcium (mg/day, continuous), and red meat intake
(g/day, continuous), and study component (OS, CT) and CT randomization assignment and treatment arm.
OS, observational study; CT, clinical trial; DFE, dietary folate equivalents; DHA, docosahexaenoic acid; EPA,
eicosapentaenoic acid; NSAIDs, non-steroidal anti-inflammatory drugs. PUFA, polyunsaturated fatty acids.
We next examined the interaction of fat and fiber subtypes in relation to CRC risk. The interaction
between DHA + EPA and soluble fiber was statistically significant (p-interaction = 0.01), with a
significant decreased risk of CRC with increasing DHA + EPA intake among those in the lowest
quintile of soluble fiber intake (p-trend = 0.02; Table 4) and a borderline increased risk of CRC with
increasing DHA + EPA among those in the highest quintile of soluble fiber (p-trend = 0.07; Table 4).
There was a marginal statistically significant association between pectins and DHA + EPA (p = 0.05),
with a similar pattern of attenuation, whereby the protective effects of higher intakes of pectins were
no longer apparent with higher intakes of DHA + EPA (data not shown). However, these interactions
were no longer significant when adjusted for multiple comparisons. There were no other significant
interactions between the various dietary fiber and fat combinations.
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Table 4. Soluble fiber and DHA + EPA stratified by quintile of intake, and association with colorectal
cancer in the Women’s Health Initiative (n = 134,017) 1993–2010.
DHA + EPA (g/Day) HR (95% CI) 1 p-Trend 2
Soluble fiber
(g/day)
Q1 Q2 Q3 Q4 Q5
Q1
1.00 0.88 0.78 0.88 0.59 0.91
0.02(Ref) 3 (0.68, 1.13) (0.59, 1.04) (0.65, 1.20) (0.40, 0.88) (0.84, 0.98)
Q2
0.81 0.82 0.91 0.80 0.91 1.03
0.44(0.62, 1.06) (0.63, 1.07) (0.70, 1.18) (0.60, 1.06) (0.69, 1.23) (0.96, 1.11)
Q3
0.71 0.84 0.73 0.65 0.79 0.99
0.70(0.53, 0.96) (0.63, 1.11) (0.55, 0.97) (0.48, 0.87) (0.59, 1.06) (0.91, 1.06)
Q4
0.76 0.86 0.87 0.90 0.77 1.00
0.96(0.56, 1.05) (0.65, 1.15) (0.66, 1.15) (0.68, 1.18) (0.57, 1.02) (0.93, 1.07)
Q5
0.70 0.53 0.73 0.81 0.80 1.08
0.07(0.49, 1.01) (0.37, 0.78) (0.53, 1.00) (0.60, 1.08) (0.60, 1.08) (1.00, 1.17)
HR (95% CI) 1
0.97 0.90 1.02 0.99 1.00
(0.89, 1.08) (0.81, 1.00) (0.92, 1.13) (0.89, 1.09) (0.89, 1.11)
p-trend 2 0.62 0.05 0.72 0.80 0.95
1 HR and 95% CI across quintiles of soluble fiber and DHA + EPA; 2 p-trend values from linear interactions across
each row and column. The following variables were included in the model: total energy intake (continuous),
age (continuous), body mass index (continuous), education (high school, technical school or some college,
college graduate or post-graduate), family history of colorectal cancer (yes/no), history of colonoscopy (yes/no),
current NSAID use (yes/no), alcohol intake (continuous), smoking history (never, former, current), physical
activity (total metabolic equivalent-hours, continuous), ever use of hormone therapy (never, current/former),
folate (µg/day, continuous), calcium (mg/day, continuous), and red meat intake (g/day, continuous), and
study component (OS, CT) and CT randomization assignment and treatment arm; 3 the combination of the
first quintiles for soluble fiber and DHA + EPA is the reference group for all comparisons within quintiles.
OS, observational study; CT, clinical trial; DFE, dietary folate equivalents; DHA, docosahexaenoic acid; EPA,
eicosapentaenoic acid; NSAIDs, non-steroidal anti-inflammatory drugs. PUFA, polyunsaturated fatty acids.
4. Discussion
The results of the present analysis in a large, prospective cohort of postmenopausal women do
not support the results obtained in preclinical studies demonstrating that combinations of higher
fiber and fat subtypes are associated with reduced risk of CRC. While there was a modest additional
protective effect of either dietary component when intake of the other was low, this protective effect was
attenuated with greater consumption in our study population. Intakes and ranges were very low such
that only women in the highest quintile of fiber were consuming adequate intakes for this age group
(21 g/day for women ages 51–70 years), with a very small percentage consuming high intakes [71].
Further, intakes of n-3 PUFA, and DHA and EPA, specifically, were substantially lower than the levels
used in experimental diets. These factors may have prevented detection of an association.
It is generally thought that CRC risk could be reduced through dietary modification, including
increased dietary fiber intake and reduced fat intake [3]. Dietary fiber mainly includes remnants of
plant foods resistant to digestion by human enzymes and therefore arrives in the colon relatively intact,
where it undergoes metabolism by gut microbiota. In the 2011 Colorectal Cancer Report, part of the
Continuous Update Project, the World Cancer Research Fund/American Institute for Cancer Research
Expert Panel classified evidence supporting consumption of fiber-containing foods and CRC protection
as ‘convincing’ [72], noting that for every 10 g/day increase in fiber, there was a 10% decrease
in CRC risk. Mechanisms hypothesized to explain how dietary fiber may reduce CRC include
increased stool bulk and reduced intestinal transit time, resulting in reduced exposure to potential
carcinogens; decreased secondary bile acids and subsequent generation of reactive oxygen species;
and fiber fermentation by gut microbiota to short-chain fatty acids, particularly butyrate [73–75].
It is now well-documented that butyrate induces apoptosis in tumor cells through inhibition of
HDAC and subsequent activation of the Fas receptor-mediated extrinsic death pathway [31,76–79].
Given the potential importance of fiber fermentation on CRC risk, consideration of fiber subtypes
may be important; however, few studies have examined fiber subtype (i.e., soluble and insoluble,
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or more and less fermentable), and associations are similar, with both null [9,10] and inverse
associations [80–83] reported.
When evaluating total fiber and subtypes in the present study, CRC risk was reduced for all
quintiles of increased consumption and a marginal linear trend was observed; however, most quintiles
did not reach statistical significance. Inconsistencies across epidemiologic studies may be attributed in
part to lower overall fiber intakes and narrow ranges of fiber intakes in Western populations which
reduce statistical power [13]. Mean fiber intake in the U.S. is ~15 g/day [4]. Intakes at or above current
recommended intakes (25 g/day for women and 38 g/day for men) [71] show robust protection against
CRC with relative risks ranging from 0.72 to 0.90 [4,6,26]. Only 10% of our study population reported
intakes of dietary fiber >25 g/day, thus our ability to detect a protective effect was compromised.
Overlaying the conflicting data observed with dietary fiber and CRC is a similar body of
inconsistent literature on the association between subtypes of fat, particularly n-3 PUFA, and CRC risk.
In addition to the anti-inflammatory effects promulgated by changes in the eicosanoid milieu, other
putative actions of n-3 PUFA have been proposed. These include alterations in membrane fluidity and
lipid raft composition, which may affect receptor signaling involved in proliferation and apoptosis [84],
and modulation of oxidative stress [57,85]. As with dietary fiber, laboratory data consistently show
reduced CRC risk with marine n-3 PUFA [58], while epidemiologic data are less convincing. Whereas
two meta-analyses reported reduced CRC risk with n-3 PUFA from fish intake [86,87], two systematic
reviews concluded that there is insufficient [15] or limited [7] evidence to suggest an association
between long-chain n-3 PUFA intake and CRC risk. A more recent publication reported no overall
association between n-3 PUFA and CRC risk among 123,529 individuals; however, among women in
the same cohort, n-3 PUFA intake after CRC diagnosis had a protective effect on survival [88].
In the WHI population, we did not observe an association between any dietary fat subtypes
and CRC risk. As with fiber, intakes of n-3 PUFA were very low; mean intakes were 1.4 g/day
(range 0.1–10.4) for n-3, and 0.04 and 0.08 g/day (range 0–1.4 and 0–3.1, respectively) for EPA and
DHA. While specific recommendations for n-3 PUFA intake have not been determined, the Food and
Nutrition Board of the Institute of Medicine established adequate intake levels for alpha-linolenic
acid (ALA), the precursor of long-chain n-3 PUFA, of 1.1 g/day for women over the age of 19 [71].
Only about half of our study population had intakes at that level. Furthermore, the Academy of
Nutrition and Dietetics recommends a minimum intake of 0.5 g/day of combined EPA and DHA [89].
Less than 2% of the women in our study cohort reached an intake level above 0.5 g/day.
Despite the inconsistent epidemiologic data for dietary fiber and fat, studies in preclinical animal
models have shown that combinations of fiber and fat work synergistically to protect against colon
cancer [58–62]. In a series of experiments, the effects of different types of fat (fish oil or corn oil;
15 g/100 g) and fiber (pectin or cellulose; 6 g/100 g) diets were tested on tumorigenesis and various
other aspects of colonocyte physiology [58,90]. Both fish oil and pectin alone, relative to corn oil
and cellulose feeding, resulted in a significantly lower proportion of animals with adenocarcinomas;
however, the combination of fish oil and pectin led to an even greater reduction [58]. Additional work
showed changes to the re-dox environment within rat colonocytes with a concomitant reduction in
DNA damage [35,59,91]. Serving as the primary energy source for colonic epithelial cells, butyrate
induces cellular reactive oxygen species (ROS) generation, creating a pro-oxidant environment [31].
At the same time, long chain n-3 PUFA from fish oil (e.g., DHA) incorporated into cell membranes, are
susceptible to oxidation due to their high degree of unsaturation [33]. These physiological attributes of
butyrate and DHA are relevant as lipid peroxidation can directly trigger the release of pro-apoptotic
factors from mitochondria into the cytosol, through a p53-independent, calcium-mediated cell death
pathway [33]. Given that butyrate independently induces apoptosis through an extrinsic, HDAC
inhibition-mediated pathway, the combination of dietary constituents, and subsequent effects on
intrinsic apoptotic pathways, would be expected to exponentially increase apoptosis.
Dietary fiber and fatty acids, in combination, and risk of CRC in humans has only recently begun
to be evaluated. In a large cohort study (n = 96,354) of Seventh Day Adventists, risk of CRC was
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reduced by 22% among all vegetarians combined compared to non-vegetarians, but protection was
greatest among pescovegetarians who consume high amounts of both fiber and n-3 PUFA-containing
fish (HR: 0.57; 95% CI: 0.40, 0.82) [92]. Furthermore, striking reciprocal changes in gut mucosal cancer
risk biomarkers, the microbiome, and the metabolome were reported after African Americans were
given a high-fiber (primarily in the form of resistant starch, including pectin), low-fat diet and rural
Africans were given a high-fat, low-fiber Western-style diet [93]. Significantly increased butyrate
production and suppressed secondary bile acid synthesis were also noted after the diet exchange to
high-fiber, low-fat intake in African Americans [93].
An analysis in the Rotterdam prospective cohort (n = 4967) lends support to the hypothesis that
higher intakes of fat and fiber are an important factor mediating the relationship between these dietary
variables. An increased risk of CRC was observed with n-3 PUFA intake and dietary fiber intakes below
the median, but not when fiber intakes were above [22]. It is noteworthy that the levels of fiber intakes
were markedly lower (mean 26 g/day) relative to the intakes among pescovegetarians in the Seventh
Day Adventist population (mean 40 g/day) and the African American intervention participants (mean
55 g/day), but higher than the intakes in our population (mean 16 g/day). Adding to the complexity of
the relationship, when evaluated by food sources of n-3 PUFA in the Rotterdam study, increased CRC
risk was restricted to intake from non-marine sources which contain ALA; there was no association
when n-3 PUFA from marine-derived (e.g., EPA and DHA) sources were evaluated [22]. Contrary
to these results, evaluation by n-3 PUFA source in a case-control study did not show any difference
between non-marine and marine sources and interaction with dietary fiber. In this instance, greater
protection of n-3 PUFA was found among individuals with lower dietary fiber intakes although overall
intake was low (median 18.6 g/day) [94], consistent with our observation of the significant reduced
risk of CRC among women with the lowest soluble fiber and highest DHA + EPA intakes. The authors
speculated that high fiber intake may interfere with lipid absorption, offsetting potential beneficial
effects of certain fatty acids [94].
While intakes in animal models do not directly translate to human intakes, the amount of fiber
and fat used in preclinical experiments is comparable, as a proportion of intake, to what is currently
recommended for humans. For example, the amount of fiber in the rat diets was 6% by weight, which is
approximately equivalent to 30 g/day for humans [58]. This level of intake was only approached in the
highest quintile of total fiber intake (>21.5 g/day). Similarly, all rat diets contained fat at 15% by weight
and 30% of energy, with fish oil comprising approximately 1%–5% [58]. Women in WHI consumed
33% of their calories from fat on average, but less than 1% from n-3 PUFA and even less from combined
DHA and EPA from fish oil (highest quintile >0.18 g/day). In the VITamins And Lifestyle (VITAL)
cohort (n = 68,109), individuals using fish oil supplements on 4+ days/week for 3+ years experienced
49% lower CRC risk than non-users (HR = 0.51, 95% CI = 0.26–1.00; p-trend = 0.06) [17]. An average
serving of oily fish (e.g., salmon or mackerel) provides 1.5–3 g of marine fish oil [95]. Thus, it may be
difficult to achieve the levels of n-3 PUFA needed for a chemoprotective effect through diet alone.
Strengths of this study include the large, well-characterized prospective cohort. As CRC was one of
the primary outcomes of WHI, incident cases were expertly adjudicated and confirmed. Additionally,
detailed information was collected on a wide range of exposures, including diet, with reliability
subsequently assessed [65]. Finally, this is the largest prospective cohort to evaluate the interactions of
subtypes of fiber and fat on CRC to date.
As with all observational studies, there are limitations. First, we relied on self-report via FFQ
to capture usual dietary intake, therefore we cannot rule out measurement error. FFQs are subject to
lack of precision and inaccurate recall of dietary intake [96]. As dietary intakes were only assessed at
baseline, it is possible that diets changed over time. However, we performed a sensitivity analysis using
FFQ from women in the Dietary Modification comparison arm (the only group for which FFQ data
from multiple time-points were collected) between years 0, 1, 3, 6, and 9, and found that correlations
were 0.62 for fiber intake and 0.44 for total fat intake, suggesting that intake remained relatively stable
during the follow-up. The WHI FFQ has been shown to yield nutrient estimates that are similar to
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those obtained from short-term dietary recall and recording methods, and test-retest reliability for
most nutrients was high (e.g., FFQ estimates for total, saturated, and polyunsaturated fat variables
were all within 10% of those from food records and 24-h recalls, although dietary fiber was slightly
higher ~17%, and information on fat and fiber subtypes was not evaluated) [67]. Our fiber exposure
also did not include the integration of dietary fiber supplement use, which is known to be higher with
age and among women [97]. Lastly, measurement of the level of EPA/DHA incorporation in plasma or
the tissue level was not conducted. It is widely known that the biological activities of these compounds
depend on their bioavailability [98] and FFQ estimates only provide a surrogate for exposure.
Finally, while we adjusted for several potential confounders, we did not directly evaluate
antioxidant content of the diet. Because the combination of butyrate and n-3 PUFA drive apoptosis via
an oxidative-dependent mechanism, higher antioxidant intakes might antagonize this protective effect.
In addition, there is some evidence that high antioxidants promote CRC in both preclinical [59,91]
and epidemiologic [99–101] studies. Although mean intakes for several individual nutrients with
antioxidant capacity (e.g., vitamins C, E, and beta-carotene) were very similar between cases and
controls at baseline (<1% difference), total antioxidant capacity of dietary intakes was not considered.
5. Conclusions
In summary, at the levels of dietary intake consumed by women in WHI, we did not find evidence
of a protective association between increased subtypes of fiber and fat intakes in combination, and
reduced risk of CRC. Our results for fat and fiber separately are in agreement with what has been
reported previously, namely modest inverse associations with fiber, but no consistent trends across
intakes. Given the biologic plausibility of a protective effect for fiber and n-3 PUFA, the robust
results from preclinical models, and the mixed results in observational studies, controlled feeding
trials with standardized intakes and consideration of the potential impact of the gut microbiome are
urgently needed.
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